Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 6, 2001, Pages 657-660

  Omar, S A ^a   Bakari, A ^c   Owiti, A ^d   Adagu, I S ^b   Warhurst, D C ^b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Tiwi Provincial Rural Health Training Centre   (Kenya)

^d Oyugis Health Centre   (Kenya)

Author keywords

Chemotherapy; Children; Co trimoxazole; Malaria; Plasmodium falciparum; Sulfadoxine pyrimethamine

Indexed keywords

CHLORCYCLOGUANIL; CHLOROQUINE; COTRIMOXAZOLE; CYCLOGUANIL; FANSIDAR; PYRIMETHAMINE; QUININE;

ANEMIA; ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESISTANCE; DRUG RESPONSE; ENDEMIC DISEASE; FEMALE; FEVER; HUMAN; INCIDENCE; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITEMIA; PRESCHOOL CHILD; RASH; SIDE EFFECT; TREATMENT FAILURE; VOMITING;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035725247     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90107-5     Document Type: Article

References (24)

1. Trimethoprim/sulphamethoxazole combination in the treatment of falciparum malaria
2. Co-trimoxazole for childhood febrile illness in malaria-endemic regions
3. Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children
4. Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole
5. Trimethoprim and sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African school children
6. Insect resistant crop plants
7. An evaluation of cotrimoxazole in the treatment of Plasmodium falciparum malaria
8. Trimethoprim-sulfamethoxazole in the treatment of malaria, toxoplasmosis and pediculosis
9. Plasmodium falciparum: Selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children
10. Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda
11. Treatment of acute falciparum malaria with sulfalene and trimethoprim
12. Malaria Control Programme, Kenya Epidemiology of malaria in Kenya
13. Chemotherapeutic efficacy of co-trimoxazole for childhood malaria in an area with multidrug resistance in Tanzania
14. Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?
15. Use of trimethoprim-sulfamethoxazole in pediatric infections: Relative merits of intravenous administration
16. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination
17. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues
18. Plasmodium falciparum: Asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant
19. Antimalarial drug discovery: Development of inhibitors of dihydrofolate reductase active in drug resistance
20. The efficacy of antifolate antimalarial combinations in Africa: A predictive model based on pharmacodynamic and pharmacokinetic analyses
21. Antimalarial drug policies: Data requirements, treatment of uncomplicated malaria, and management of malaria in pregnancy
22. Assessment of therapeutic efficacy of antimalarial drugs: For uncomplicated falciparum malaria in areas with intense transmission
23. Clinical trials with Fansidar, Bactrim and chloroquine in 300 cases of acute falciparum malaria
24. Childhood mortality during and after hospitalization in western Kenya: Effect of malaria treatment regimes